Newsroom | 2807 results

Sorted by: Latest

Veterinary
-

IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial results for Monday, February 2, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q4 2025 Earnings Snapshot through a link on...
-

CATalyst Council Releases “Key Feline Market Insights from 2025,” Highlighting a Pivotal Year for Feline Health, Veterinary Growth, and Industry Innovation

ANNAPOLIS, Md.--(BUSINESS WIRE)--A top-line view of distinct opportunities for feline health across the veterinary profession, and for cats across the entire pet health industry....
-

Kradle Expands Calming Portfolio With Kradle Max Full-Spectrum Hemp Calming Tincture for Dogs

MINNEAPOLIS--(BUSINESS WIRE)--Kradle, a premium pet wellness brand known for its thoughtfully formulated and easy-to-use natural calming solutions, today announced the launch of Kradle Max Full-Spectrum Hemp Calming Tincture for Dogs. The new vet-formulated liquid supplement expands Kradle’s growing calming portfolio, offering pet parents another flexible format to support dogs during particularly challenging or high-stress moments. Kradle Max is made with full-spectrum hemp extract, a naturall...
-

Veterinary Telemedicine Company Dutch Appoints Dr. Kate Elden as Chief Medical Officer and Michael Parness as Chief Marketing Officer

OAKLAND, Calif.--(BUSINESS WIRE)--Dutch, the leading veterinary telehealth platform, today announced the appointments of Dr. Kate Elden, DVM, as Chief Medical Officer and Michael Parness as Chief Marketing Officer. The executive hires underscore Dutch’s next phase of growth as the company scales its brand and continues advocating for the future of veterinary telemedicine. As Chief Medical Officer, Dr. Elden will oversee Dutch’s clinical strategy, including scaling its affiliated veterinarian ne...
-

Immuto Scientific Announces Research Collaboration with a Leading US-Based Multinational Animal Health Company

CAMBRIDGE, Mass. & MADISON, Wis.--(BUSINESS WIRE)--Immuto Scientific Announces Research Collaboration with a Leading US-Based Multinational Animal Health Company...
-

Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2026 on Wednesday, February 4, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on February 4, 2026. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive Officer James F. Cleary, Executive Vice President &...
-

CATalyst Council Appoints Gina Fortunato as Executive Director

ANNAPOLIS, Md.--(BUSINESS WIRE)--CATalyst Council, a 501(c)(3) organization dedicated to improving the lives of cats and their caregivers, today announced the appointment of Gina Fortunato as Executive Director. Fortunato succeeds Dr. Jane Brunt, a key partner in the origin of the organization and who will continue as a Senior Advisor to ensure a seamless transition. "Gina brings an extraordinary combination of industry expertise, nonprofit leadership, and deep commitment to CATalyst's mission,...
-

Parnell Expands Veterinary Anesthesia Portfolio with Isoflurane

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Parnell is proud to announce the launch of its new Isoflurane Inhalation Anesthetic, a nonflammable and nonexplosive solution designed for the induction and maintenance of general anesthesia in horses and dogs. Available in 250 mL bottles, Parnell’s Isoflurane provides veterinary clinics with a reliable, cost-effective alternative to existing options, ensuring safe and efficient anesthesia care. “We are pleased to introduce Isoflurane as part of Parnell’s c...
-

Bond Vet Reports 40% Same-Store Visit Growth on a Trailing Twelve-Month Basis Despite Industry-Wide Softening

NEW YORK--(BUSINESS WIRE)--While the broader veterinary industry continues to experience a decline in overall patient visits, Bond Vet is significantly outperforming the market, reporting 40% same-store visit growth on a trailing twelve-month basis, comparing the same calendar months year over year. Veterinary providers across the U.S. are facing post-pandemic normalization, affordability pressures, and workforce constraints that have softened demand. Against this backdrop, Bond Vet’s results h...
-

Paw Prosper Acquires Canine Rehabilitation Institute, Expanding Commitment to Advanced Pet Care

DENVER--(BUSINESS WIRE)--Paw Prosper acquires Canine Rehabilitation Institute, expanding professional education, certification, and hands-on training in pet care....